GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acorda Therapeutics, Inc. (ACOR) [hlAlert]

Rating:
Buy ACOR
down 1.33 %

Acorda Therapeutics, Inc. (ACOR) rated Buy with price target $34 by Lazard Capital

Posted on: Tuesday,  Feb 24, 2009  2:25 PM ET by Lazard Capital

Lazard Capital rated Buy Acorda Therapeutics, Inc. (NASDAQ: ACOR) on 02/24/2009. Previously Lazard Capital rated Buy Acorda Therapeutics, Inc. (NASDAQ: ACOR) on
07/22/2008., when the stock price was $32.12. Since then, Acorda Therapeutics, Inc. has lost 1.34% as of 01/26/2016's recent price of $31.69.
If you would have followed the previous Lazard Capital's recommendation on ACOR, you would have lost 1.33% of your investment in 2744 days.

Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Our goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Our industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/24/2009 2:25 PM Buy
None
25.08 34.00
as of 12/31/2009
1 Week down  -7.20 %
1 Month down  -0.45 %
3 Months up  2.96 %
1 YTD up  16.86 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/22/2008 8:25 AM Buy
None
32.12 39.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy